ACE2 maybe serve as a prognostic biomarker in breast invasive carcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.24362
Abstract: Breast cancer is a frequently occurring malignant tumor in women. Angiotensin‐converting enzyme 2 (ACE2) is widely expressed in most organs; however, the association of ACE2 with prognosis and immune infiltration in breast invasive carcinoma (BRCA)… read more here.
Keywords: breast; breast invasive; invasive carcinoma; ace2 maybe ... See more keywords